Antibiotic Duration for Bacterial Endophthalmitis
Intravitreal antibiotics should be administered as a single dose at the time of diagnosis, with repeat injections only if there is inadequate clinical response at 48-72 hours; systemic antibiotics should be continued for 7-14 days depending on the source and severity of infection.
Intravitreal Antibiotic Therapy
The cornerstone of endophthalmitis treatment is immediate intravitreal antibiotic injection - timing is critical, with treatment within 2 hours of presentation associated with significantly better visual outcomes 1. The standard approach involves:
- Single intravitreal injection of broad-spectrum antibiotics (vancomycin 1.0 mg/0.1 mL for gram-positive coverage plus ceftazidime 2.25 mg/0.1 mL or amikacin 0.4 mg/0.1 mL for gram-negative coverage) 2
- Repeat intravitreal injection is only indicated if clinical response is inadequate at 48-72 hours follow-up
- The intravitreal route achieves therapeutic levels directly in the vitreous cavity, which is the primary site of infection
Historical data from the 1970s-1980s established that intravitreal gentamicin (400 mcg) with dexamethasone (360 mcg) cured 11 of 12 cases with a single injection 3. Modern practice continues this single-dose approach unless clinical deterioration occurs.
Systemic Antibiotic Duration
Systemic antibiotics serve an adjunctive role and duration depends on the clinical scenario:
Post-Operative/Post-Traumatic Endophthalmitis
- 7-10 days of intravenous broad-spectrum antibiotics (vancomycin plus ceftazidime or amikacin) 2
- Can transition to oral antibiotics after clinical improvement (typically 3-5 days)
- Systemic therapy is particularly important when there is scleral extension or concern for systemic seeding
Endogenous Endophthalmitis
- 14 days or longer of systemic antibiotics, guided by the source of infection 4
- Requires collaboration with internal medicine/infectious disease specialists
- Duration determined by the primary source (endocarditis requires 4-6 weeks, gastrointestinal sources typically 2-3 weeks)
- 93% of endogenous cases have an identifiable systemic source, most commonly endocarditis and gastrointestinal tract 4
Topical Antibiotic Duration
- Fortified topical antibiotics (vancomycin 50 mg/mL and ceftazidime 50 mg/mL or tobramycin 14 mg/mL) should be administered hourly initially
- Continue for 7-14 days with gradual tapering based on clinical response 2
- Topical therapy alone is insufficient but provides additional anterior segment coverage
Critical Timing Considerations
The single most important factor is speed of initial treatment - every hour of delay worsens outcomes 1. Patients treated within 2 hours have significantly better final visual acuity compared to those treated later. This emphasizes that the focus should be on immediate single-dose intravitreal therapy rather than prolonged courses.
Common Pitfalls to Avoid
- Do not delay intravitreal antibiotics waiting for culture results - empiric broad-spectrum coverage should be initiated immediately
- Do not routinely give multiple intravitreal injections - this increases risk of retinal toxicity without proven benefit unless there is documented clinical failure
- Do not rely on systemic antibiotics alone - they do not achieve adequate intraocular levels in the vitreous cavity
- Do not stop systemic antibiotics prematurely in endogenous cases - the underlying systemic infection requires full treatment duration
Role of Vitrectomy
While not strictly about antibiotic duration, vitrectomy timing affects overall treatment duration. Early complete vitrectomy may reduce the need for prolonged antibiotic therapy by mechanically removing the infectious burden 5, though this remains an area of ongoing investigation beyond the original EVS guidelines.
The evidence base for specific antibiotic duration in endophthalmitis is largely derived from expert consensus and retrospective series 2, 4, 6 rather than randomized trials, but the principle of immediate single-dose intravitreal therapy with adjunctive systemic coverage for 7-14 days represents the current standard of care.